Total Shoulder Arthroplasty Multi-Center Registry

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-100
SponsorArthrex, Inc.

About this trial

The objective of the study is a multi-center prospective registry to collect clinical outcomes of anatomic and reverse total shoulder arthroplasty.

Eligibility criteria

Qualifiers

Patient voluntarily consents to participate in the study and has the mental and physical ability to participate in the study, fill out subjective questionnaires, return for follow-up visits, and comply with prescribed post-operative physical therapy.

Patient is between the ages of 18 and 100 years.

The patient has a planned primary or revision implantation of an anatomic (hemi-arthroplasty or total arthroplasty) or a reverse shoulder prosthesis system manufactured by Arthrex.

Patient has a standard of care preoperative CT taken within 6 months that has been submitted for Arthrex VIP (Virtual Implant Positioning) planning.

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

No trial groups listed

Locations

24
Germany
Orthopädische Chirurgie München (OCM)81369, München Germany
Switzerland
Schulthess Klinik8008, Zurich Switzerland
United States
Arizona
Banner Medical Group85016, Phoenix United States
University of Arizona/Banner Health85006, Phoenix United States

Sponsors and collaborators

Arthrex, Inc.

Lead sponsor